“Since the launch of the ‘Intelligent Assist’ solution in 2020, we have been actively listening to the needs of our customers and have reflected the needs of the market into our enhanced AI-based image processing technologies and diagnostic assistance functions,” said Won-Chul Bang, Vice President, Head of Customer Experience Team at Samsung Medison. “We will actively introduce various ultrasound diagnosis solutions to meet customers’ needs in the future preemptively.”

Samsung is launching its enhanced ‘Intelligent Assist’ software in its premium ultrasound device, HERA W10, and will be presenting its clinical values for “Improving Accuracy and Efficiency” for fetal anomaly detection using its AI solutions during the online symposium on October 17^th.

‘Intelligent Assist’ solution includes ‘Biometry Solution’ for assessment of the fetal growth and ‘Fetal Heart Solution’ for the assessment of the fetal heart.

‘Biometry Solution’ recognizes images such as the fetal head, abdomen, lower extremities and others and measures the fetal growth and development while the ‘Fetal Heart Solution’ recognizes the view of the fetal heart, annotates the images and measures the necessary fetal heart structures for a thorough fetal heart anomaly assessments.

During the symposium, Aris Papageorghiou, Clinical Research Director of the Maternal and Perinatal Health Institute at Oxford UK and the professor in obstetrics and fetal medicine at St George’s University Hospitals UK, will be introducing his clinical experiences with Samsung’s ‘Intelligent Assist’ solutions.

Hye-Sung Won, professor of the Department of Obstetrics and Gynecology at Asan Medical Center, Korea, will introduce the MPI+ that semi-automatically measure LV MPI and RV MPI to analyze the fetal heart function. She will also be presenting her findings of the feasibility and reliability of ‘Fetal Heart Solution’ in automatically providing complex fetal heart view image classifications and fetal heart structural measurements.

In addition, Samsung will be introducing its high-end versatile ultrasound device ‘V8’, first released on September 30^th, at the virtual exhibition hall during ISUOG 2021.

‘V8’ will include some of the enhanced solutions that are dedicated to the premium ultrasound system such as MV-Flow, a novel alternative to power Doppler for visualizing the slow flow of micro-vascularized structures, and LumiFlow, three-dimensional visualization of blood flow which helps the user understand the structure of small vessels intuitively. ‘V8’ will also include some of the ‘Intelligent Assist’ solutions to cater to the needs of the larger busy hospitals.

For more information on Samsung’s healthcare division, its subsidiaries and products, please visit https://www.samsunghealthcare.com.

The image delineates that the fetal head is automatically recognized and measured along with the fetal growth when ‘Biometry Solution’ is executed.

The feature automatically recognizes and annotates the anatomy of the fetal heart and displays measured values when the ‘Fetal Heart Solution’ is executed.

About Samsung Medison
Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

“It’s very meaningful to launch the V8, a new premium medical device that addresses many customer needs,” said Won-Chul Bang, Vice President, Head of Customer Experience Team, Samsung Medison. “We expect V8 to become a flagship product of premium ultrasound systems as it is uniquely designed to cover different medical specialties.”

V8’s “V” stands for “Versatile,” meaning that the advanced functions from premium ultrasound systems dedicated to specific departments such as obstetrics, radiology, orthopedics and cardiology have been implemented.

Several diagnostic assistance functions of a premium ultrasound system for obstetrics and gynecology include MV-Flow which is suitable for observing the presence of microvascular blood flow, low-velocity blood flow and LumiFlow which provides three-dimensional visualization of blood flow in a two-dimensional image, allowing the medical staff a more realistic assessment of the vascular structures and flow.

For radiology, V8 is equipped with S-Shearwave Imaging which provides information about tissue stiffness as a result of disease using ultrasonic transverse elasticity. V8 also features S-Fusion which allows synchronous alignment of medical images of ultrasound with one or more cross-sectional studies such as MRI which are instantly reconstructed in the corresponding plane.

On the other hand, it is also expected to be equipped with a NerveTrack which has been cleared by the U.S. Food and Drug Administration (FDA) as an AI medical device and can be used to treat musculoskeletal diseases that track nerve locations in pain areas in real time.

In addition, by introducing a 23.8″ LED monitor and a 14″ high-sensitivity touch panel, user convenience has been enhanced to perform various procedures.

The screen that automatically tracks the nerve’s location on the wrist in real time with the NerveTrack function is executed.

About Samsung Medison

Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.

Samsung showcases premium new ultrasound systems ‘HERA W10’ and ‘HERA I10’ at ISUOG World Congress 2018

HERA is a new premium platform which stands for Hyper-aperture Enhanced Reconstruction Architecture, incorporating Samsung’s new Crystal Architecture to provide advanced technology and capabilities with a new level of image quality. Samsung’s new platform combines Crystal Architecture with an advanced transducer technology called S-Vue. It allows an 11-fold increase in processing power and 10 times the data transfer speed of Samsung’s previous system. It is expected to facilitate the examination of high-risk pregnancies and early diagnosis of abnormal fetus conditions.

“Samsung is proud to introduce a new premium ultrasound system HERA W10 and a form factor innovation ultrasound HERA I10, as well as solutions that greatly improve the efficiency of hospitals,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “Samsung will continue to provide the best solutions possible and bring meaningful changes in the healthcare industry.”

New features for Samsung’s HERA W10 ultrasound system offer clinicians an optimized workflow and more information to overcome challenges, including:

Outstanding Image Quality

• Crystal Architecture – Offers a superior image with single crystal probe technology S-Vue, a new beamforming technology CrystalBeam and an advanced post-processing engine CrystalLive.
• ShadowHDR – Provides a shadow suppressed image, especially applicable to highly attenuated regions such as fetal head and spine.
• HQ-Vision – Allows users get high resolution images to detect clinically important details.

New Samsung Exclusive Technologies

• MV-Flow – Offers a detailed view of blood flow in relation to the surrounding tissues or pathology with an enhanced spatial and temporal resolution.
• LumiFlow – Provides a three-dimensional visualization of continuous and volumic vascular image.

Seamless Workflow

• Wide Control Panel – Adopted rotatable control panel with a top-notch swivel mechanism. Allows moving range of 550mm from left to right and 219mm from top to bottom.
• Touch Customization – Allows users to easily change the position of the button on the touchscreen for each mode and feature.

In addition to HERA W10, Samsung is unveiling a prototype of HERA I10, which shares the same platform as HERA W10, but with a completely new ergonomic redesign. HERA I10 is a next-generation chair-type ultrasound system with a design that is entirely different from the industry norm that meets the unique needs of Ob/Gyn professionals. HERA I10 provides a comfortable experience for both the doctor and the patient by addressing the discomfort caused by the spacing and the position of the clinicians and eliminating the need for the patient to shift the body, as it automatically adjusts for proper positioning. It also reduces the force required to move the control panel back and forth and the resistance force on the wrist.

A new ultrasound solution SonoSync will also be introduced, which allows healthcare professionals to see real-time ultrasound scanning images in remote places¹. SonoSync provides two-way communications through voice chatting and marking, improving accessibility. It can be installed on various devices such as smartphones, laptops and desktop PCs, allowing multilocation real-time training and education among healthcare professionals. Its Multiview feature also increases productivity by viewing multiple image scans in one screen.

For more information on Samsung’s healthcare division, its subsidiaries and products please visit https://www.samsunghealthcare.com.

¹SonoSync may not be used for diagnostic purposes at all times. Its availability may vary in different countries, according to regulatory approvals.

About Samsung Medison

Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.